Table 1.
Number of patients | ||
---|---|---|
Characteristics | 31* | |
Gender | ||
Female | 17 | 54.80% |
Male | 14 | 45.16% |
Race | ||
AA | 31 | 100% |
Grade** | ||
High | 10 | 32.26% |
Low | 20 | 64.52% |
Tumor size** | ||
≥2 | 6 | 19.35% |
≤2 | 24 | 77.42% |
LN positive** | ||
≥2 | 20 | 64.52% |
≤2 | 10 | 32.26% |
Stage T** | ||
≥2 (T1–T2) | 7 | 22.58% |
≤2 (T3–T4) | 21 | 67.74% |
Stage N** | ||
N0 | 10 | 32.26% |
N1–N3 | 18 | 58.06% |
NOTE:
Patients missing due to the lack of clinical characteristics or tissue damage was excluded from the analysis.
Data are missing for few patients.